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doi:10.1016/j.ejvs.2010.06.013Abstract Objectives: There is strong evidence of a genetic predisposition to abdominal
aortic aneurysm (AAA), however the genes involved remain largely elusive. Recently, two large
studies have suggested an association between the angiotensin converting enzyme gene and
AAA. This study aimed to investigate the possible association between the ACE insertion/dele-
tion polymorphism and abdominal aortic aneurysm (AAA) in order to replicate the findings of
other authors.
Design and Methods: A case-control study was performed including 1155 patients with aneu-
rysms and 996 screened control subjects. DNA was extracted from whole blood and genotypes
determined in 1155 AAAs and 996 controls using a two stage polymerase chain reaction (PCR)
technique.
Results: The groups were reasonably matched in terms of risk factors for AAA. No association
was found between the ACE gene insertion/deletion polymorphism and AAA in this study.
Conclusions: This study cannot support the findings of previous authors and provides evidence
against a link between the ACE gene insertion/deletion polymorphism and AAA.
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Abdominal aortic aneurysm (AAA) remains a major cardio-
vascular disease. Although the cause is unknown, there is
convincing evidence of a genetic predisposition with
increased susceptibility in first degree relatives of affected
patients. The heritability is approximately 0.7 and various
genetic models have been proposed. Unfortunately thed by Elsevier Ltd. All rights reserved.
458 B. Obukofe et al.current available data does not fit any simple Mendelian
mode of inheritance and segregation analyses suggest
a multi-factorial model.
The candidate gene approach has been used to study the
Angiotensin Converting Enzyme (ACE) gene polymorphism
which has been implicated in both cardiovascular diseases
and AAA. A recent meta-analysis in 2008 of available data
showed a significant association between an ACE intronic
insertion/deletion (I/D) polymorphism and the presence of
an AAA. More recently a combined analysis of three data-
sets has confirmed this association.1
However, it is important to replicate new genetic find-
ings in an independent cohort. Therefore we investigated
this association in a separate study to determine whether
there is a genuine link between the ACE I/D polymorphism
and AAA.
Methods
We performed a case-control study of patients with AAA
recruited from three sources e vascular out-patient clinics,
a local ultrasound-based screening programme (in 65 year-
old men) and vascular admissions to a University teaching
hospital with appropriate ethical approval. Controls were
recruited from the same sources; predominantly from the
screening programme. Cases and controls were screened
for AAA by ultrasound or computed tomography. An AAA
was defined as a maximum abdominal aortic diameter
>3 cm.
We collected demographic and risk factor data including
age, sex, smoking history, family history of AAA, history of
hypertension (BP > 140/90 or pharmacological treatment),
hyperlipidaemia (total cholesterol > 5.5 mmol/l or phar-
macological treatment), diabetes mellitus, and presence of
coronary artery disease (previous myocardial infarction,
coronary angioplasty or surgery).
Genotyping
DNA extraction was performed from whole blood derived
buffy coats using a commercial kit (Puregene, Gentra,
USA). The ACE insertion deletion polymorphism was
determined by a two stage polymerase chain reaction
(PCR) method. First stage touchdown PCR was performed
using a 50 yl PCR mix consisting of 100 ug of genomic
DNA, 10 pmol of each primer, 50 mmol of KCL, 10 mmol
Tris, 200 mmol each dNTPs, 1 unit taq polymerase, 0.1%
Triton X-100 and 5% DMSO. Primer sequences were as
follows:
Forward CTGGAGACCACTCCCATCCTTTCT
Reverse GATGTGGCCATCACATTCGTCAGAT
The PCR reaction consisted of 5 min initial denaturation
at 94 C, followed by 35 cycles of a touchdown stage from
66 C to 56 C at 1 min each, an elongation stage of 2 min at
72 C and a denaturation stage at 94 C for 1 min, with final
elongation at 72 C for 5 min.
PCR products were visualised on agarose gels with
amplicons of 191 base pairs indicating the presence of thedeletion polymorphism and 491 base pairs indicting the
presence of the insertion polymorphism.
All samples homozygous for the deletion (DD) underwent
a second PCR in order to check for mistyping of heterozy-
gotes which can occur in up to 5% of cases. In these
samples, PCR products from the primary PCR were sub-
jected to a second stage PCR using an insertion specific
primer,
(TTTGAGACGGAGTCTCGCTC), and forward and reverse
primers as follows:
ForwardTGGGACCACAGCGCCCGCCACTAC
ReverseTCGCCAGCCCTCCCATGCCCATAA:
PCR master mix was as above except for the addition of
the insertion specific primer at 2.5 pmol, PCR products from
the primary PCR and a non touchdown PCR with an
annealing temperature of 64 C. Amplicons from this
reaction were visualised on agarose gels where a 338
basepair PCR product was visible in cases where heterozy-
gotes had been wrongly typed as DD homozygotes.
Statistics
The Chi squared test was used to detect deviation from
HardyeWeinberg equilibrium. Genotype frequencies in AAA
and controls were compared using the CochraneArmitage
trend test and binary logistic regression. All statistical tests
were carried out using SPSS v14.0 and p values of less than
0.05 were considered significant.
Results
There were 1155 AAAs (87% male) and 996 controls (97%
male). Power calculations demonstrated the study groups
to be sufficiently large, with 310 patients in each arm
required to reach 90% power. The median age of patients in
the aneurysm group was 73 years (range 47e96) and those
in the control group was 66 years (range 51e98). Mean
aneurysm diameter was 5.2 cm (SD 1.77). Demographic
data is shown in Table 1. There was no evidence of devia-
tion from HardyeWeinberg equilibrium in either the AAA or
control group (pZ 0.61 and pZ 0.67 for controls and AAAs
respectively, Pearson Chi squared). Genotype and allele
frequencies are shown in Table 2.
There was no evidence of association for either alleles or
genotypes between the ACE I/D polymorphism and AAA.
The overall per allele odds ratio for the D allele (risk allele)
was 0.969 (p Z 0.61, Chi squared Z 0.27,
CochraneArmitage test for trend). Genotype specific odds
ratios were compared by binary logistic regression. For I/D
compared to I/I, the odds ratio was 0.976 (95% confidence
interval 0.79e1.21, pZ 0.83), and for D/D compared to I/I,
the odds ratio was 0.94 (95% CI 0.74e1.20, p Z 0.61).
Discussion
Our data investigated the association between the intron 16
insertion/deletion (I/D) polymorphism of the ACE gene and
AAA in an appropriately powered study. We aimed to
Table 1 Demographic data for AAAs (n Z 1155) and controls (n Z 996). Numbers in brackets are percentages.
MI Z myocardial infarction. Data were missing or incomplete for: smoking 26 AAAs, 0 controls; diabetes 95 AAAs, 10 controls;
hyperlipidaemia 40 AAAs, 6 controls; MI 81 AAAs, 143 controls; hypertension 54 AAAs, 12 controls and family history 208 AAAs, 12
controls.
AAAs (%) Controls (%)
Current smokers 287 (25) 147 (15)
Ex smokers 733 (65) 543 (55)
Diabetes mellitus (all) 105 (10) 108 (11)
Insulin dependent 38 (4) 35 (4)
Non-insulin dependent 67 (6) 73 (7)
Hyperlipidaemia 397 (36) 204 (21)
Previous MI 278 (26) 89 (10)
Hypertension 685 (62) 395 (40)
Positive family history 86 (9) 50 (5)
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this singe nucleotide polymorphism (SNP) and AAA in
a pooled analysis of three cohorts e the largest study
published to date.1 We failed to find any evidence of an
association between the ACE I/D polymorphism and AAA.
Genetic factors are important in AAA and the candidate
gene approach has examined several SNPs. Two compre-
hensive reviews have examined the role of genetic factors
and candidate genes in AAA.2,3 Unfortunately many of the
genetic association studies have produced confusing results
because of lack of power and failure to replicate the find-
ings in an independent cohort e both fundamental errors of
methodology in genetic studies.
Angiotensin converting enzyme (ACE) may be important
in AAA because of the relationship between the renin
angiotensin system (RAS) and blood pressure e a known risk
factor for AAA. In animal models, angiotensin II infusion
induces AAA formation4 and inhibition of the RAS reduces
aortic elastic degradation.5 ACE inhibitors have also been
associated with a decreased risk of aneurysm rupture.6
Several studies have investigated the association of an
insertion/deletion polymorphism in intron 16 of the ACE
gene (with D being the risk allele) with mixed results. In
1999, Hamano et al. found no association between the I/D
polymorphism and AAA in 125 patients compared with 153
controls.7 In 2001 Pola et al. demonstrated a positive
association between the D allele and AAA in normotensive
but not hypertensive AAA patients. However the sample
size was again small (124 AAA, 112 controls) and the study
was underpowered.8 Similar findings were reported by
Fatini et al. in another underpowered study consisting of
250 AAAs and 250 controls.9Table 2 Genotype and allele frequencies. Numbers in brackets
AAAs
Genotype
I/I 258 (22.3)
I/D 568 (49.2)
D/D 329 (28.5)
Allele
I 1084 (46.9)
D 1226 (53.1)Recently Jones et al. have reported the largest study to
date on ACE gene polymorphisms and AAA in 1226 AAAs and
1723 controls. Using pooled data from three independent
cohorts, they investigated the role of four functional
polymorphisms of the ACE gene (including the I/D SNP) and
AAA and showed a weak association with the D allele and
a stronger association with the angiotensin II type 1a
receptor 1166 C allele. Our study was designed to replicate
the positive association between AAA and the I/D SNP.
The strength of our study is the large sample size which
was appropriate to test the null hypothesis. Although we
only used a single method for genotyping, this is a reliable
genotyping method and all subjects who were found to be
homozygous for the deletion underwent repeat PCR in
order to check for error. However in our cohort of 1155
patients with aneurysms and 996 control subjects, we can
find no association between the I/D polymorphism and AAA
and cannot support the recent findings that suggest an
association exists.1 The reasons for this are not entirely
clear. The Jones et al. study only showed a weak associa-
tion among a study group which was suitably powered but
with an exclusively male study population, which may
perhaps be a confounding factor.
In the future it is likely that a genome wide association
study (GWAS) technique will replace the candidate gene
approach. GWAS allows investigation of the common
genetic variation that causes disease using high throughput
genomic platforms. The value of this approach has recently
been demonstrated by the Wellcome Trust Case-Control
Consortium (WTCCC) which investigated genetic variants in
common diseases.10 An SNP on chromosome 9p21 which was
shown to be associated with coronary heart disease hasare percentages. I Z insertion, D Z deletion.
Controls
216 (21.7)
487 (48.9)
293 (29.4)
919 (46.1)
1073 (53.9)
460 B. Obukofe et al.since been shown to have an association with AAA.11,12
Several groups have adopted the GWAS approach for AAA
and initial results should be available within the next few
months.
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